Quanome Technologies, Inc.

Quanome Technologies, Inc., formerly known as Lakeside Holding Limited, is a holding company whose primary operating business consists of pharmaceutical distribution in the People's Republic of China conducted through its operating subsidiary, Hupan Pharmaceutical. The company acts as a midstream distributor between pharmaceutical manufacturers and medical end customers, sourcing products from various suppliers without manufacturing them directly. Its core product categories include specialty pharmaceuticals, infusion products, and foods for special medical purposes, which it markets primarily through agents to hospitals, healthcare providers, and other pharmaceutical distributors. In addition to its distribution activities, the company is developing initiatives to provide dedicated artificial intelligence compute infrastructure and managed inference services through its subsidiary XDT Infrastructure I, LLC, alongside early-stage explorations in quantum-related technology applications through Quantum Nexus.

The company's commercial operations are based in the People's Republic of China, where it served more than 60 customers during the fiscal year ended June 30, 2026. Quanome Technologies is organized under the laws of Nevada. As of June 30, 2026, the company employed a workforce of 27 full-time personnel across its business functions.

Summary of the business section of Quanome Technologies's latest annual report, written by StockData.

“As of June 30, 2026, we had a total workforce of 27 full-time employees across various functions.”